Bayhill Therapeutics' Series C Round

Bayhill Therapeutics raised a round of funding on July 15, 2009.

Bayhill Therapeutics Inc. is a clinical-stage biotechnology company focused on developing and commercializing therapeutics that fundamentally alter the way autoimmune diseases are treated. The company…

Articles about Bayhill Therapeutics' Series C Round: